Cargando…
Rituximab Administration in Third Trimester of Pregnancy Suppresses Neonatal B-Cell Development
We describe the effect on the neonate of administration of rituximab to a woman with idiopathic thrombocytopenic purpura (ITP). Rituximab, an anti-CD20 antibody, was given weekly for 4 weeks to a woman with ITP in her third trimester of pregnancy. One month after the last rituximab administration a...
Autores principales: | Klink, D. T., van Elburg, R. M., Schreurs, M. W. J., van Well, G. T. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2438602/ https://www.ncbi.nlm.nih.gov/pubmed/18596903 http://dx.doi.org/10.1155/2008/271363 |
Ejemplares similares
-
COVID-19 in third trimester of pregnancy
por: Yadiki, JosnaVinutha, et al.
Publicado: (2023) -
Pemphigoid Gestationis in a Third Trimester Pregnancy
por: Şentürk, Şenol, et al.
Publicado: (2014) -
Henoch-Schönlein purpura in the third trimester of pregnancy
por: Djakovic, Ivka, et al.
Publicado: (2018) -
Cervical Adenoma Malignum in Third Trimester Pregnancy
por: Pannecoeck, Katelijn, et al.
Publicado: (2021) -
Corneal Biomechanical Changes in Third Trimester of Pregnancy
por: Bujor, Inna Adriana, et al.
Publicado: (2021)